Oral News and Research

RSS

New gene identified for cerebral venous thrombosis

Researchers have identified a new gene linked to cerebral venous thrombosis, a condition that causes blood clots in the veins of the brain that can lead to stroke.

8 Jan 2008

A look at China's most innovative health biotechnology companies

Government funds innovation but venture capital needed; Wary investors 'need to be shown the exits'; Returning 'sea turtles' bring expertise, international credibility

8 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008

Treating children with severe pneumonia at home is just as effective as treating them in hospitals

The study results could significantly change the way the illness is managed in developing countries, saving a significant number of lives every year and taking pressure off health systems.

7 Jan 2008

Daiichi Sankyo, Lilly submit NDA for investigational antiplatelet drug, Prasugrelin U.S.

Daiichi Sankyo Company, Limited and Eli Lilly and Company have announced that on Wednesday, Dec. 26, 2007, they submitted a New Drug Application (NDA) for prasugrel to the U.S. Food and Drug Administration (FDA).

7 Jan 2008

Experts say children with severe pneumonia are better off being treated at home

The World Health Organisation (WHO) says children with severe pneumonia are better off being treated at home instead of sending them to hospital.

6 Jan 2008

Polyphenols in wine may help prevent cavities

A class of chemicals in red wine grapes may significantly reduce the ability of bacteria to cause cavities, according to a study published recently in the Journal of Agricultural and Food Chemistry.

3 Jan 2008

Researchers seek to make cavity-causing bacteria self-destruct

Bacteria that eat sugar and release cavity-causing acid onto teeth may soon be made dramatically more vulnerable to their own acid.

3 Jan 2008

Bisphosphonates appear to reduce the risk of jaw degradation

Athanasios Zavras began receiving messages from distraught patients in 2005 after case reports linked oral osteoporosis meds to bone death in the jaw.

3 Jan 2008

Study to look at effect of high dose vitamin C on non-Hodgkin lymphoma patients

Scientists at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients.

3 Jan 2008

New therapy reduces mortality in patients with severe COPD

Patients with severe COPD may benefit more from therapy that combines salmeterol and fluticasone [SFC] than treatment with tiotropium, according to results from a long-term, multi-center study, "Investigating New Standards for Prophylaxis in Reducing Exacerbations" (INSPIRE) that directly compared the two therapies.

2 Jan 2008

Catathrenia, or sleep related groaning can be successfully treated with CPAP

Catathrenia, or sleep related groaning, is an uncommon feature of a sleep-related breathing disorder that can be successfully treated with continuous positive airway pressure (CPAP), according to a study published in the January 1 issue of the journal SLEEP.

2 Jan 2008

Drug effective for hepatitis C patients with low platelets

For patients with hepatitis C, having a low blood platelet count is a frequent complication associated with advanced disease.

2 Jan 2008

Discovery of potential oral treatment for diabetes

Research in the Department of Biology at the Faculty of Science and Science Education of the University of Haifa has discovered a substance that may become an oral treatment for diabetes and its complications.

28 Dec 2007

Oral diabetes medication - new guidelines

A pair of plain-language guides that outline the latest scientific evidence on the effectiveness and safety of oral medications for adults with type 2 diabetes are now available from HHS' Agency for Healthcare Research and Quality.

18 Dec 2007

Study looks at denosumab in preventing bone loss caused by aromatase inhibitors

Denosumab is a new drug being studied to prevent fractures in breast cancer patients receiving hormonal therapy.

17 Dec 2007

Targeted therapy and chemotherapy shrinks breast cancer metastases in brain

A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber Cancer Institute investigators at the San Antonio Breast Cancer Symposium.

17 Dec 2007

Barr sues Watson and Sandoz for Seasonale patent infringement

Barr Pharmaceuticals, Inc. (NYSE:BRL) today announced that its wholly-owned subsidiary, Duramed Pharmaceuticals, Inc. has filed suits against Watson Pharmaceuticals (NYSE:WPI) and against Sandoz, a subsidiary of Novartis (NYSE:NVS) for infringement of the patent protecting Duramed's SEASONALE(R) extended-cycle oral contraceptive product.

17 Dec 2007

New UIC center to study end-of-life transition

The University of Illinois at Chicago College of Nursing has received a federal grant to create a center to study people as they transition to the end of life.

14 Dec 2007

Early results show promise in reducing side effects from anastrozole

A common osteoporosis drug can shield women against the loss of bone mineral density - a side effect of the drug anastrozole which is taken to prevent breast cancer in the IBIS-2 study - according to new data presented at the San Antonio Breast Cancer Symposium.

14 Dec 2007